ALPRAZOLAM GRINDEKS 0.5mg tablets medication leaflet

N05BA12 alprazolam • Nervous system | Anxiolytics | Benzodiazepine derivatives

Alprazolam is a medication from the benzodiazepine class, primarily used to treat anxiety disorders, panic attacks, and, in some cases, insomnia. It works by enhancing the effect of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces excessive brain activity, thereby inducing a calming and anxiolytic effect.

Alprazolam is administered orally in tablet form, with the dosage adjusted based on the severity of symptoms and the patient's response to treatment. It is typically prescribed for short-term use, as prolonged use can lead to tolerance, dependence, and withdrawal symptoms.

Common side effects include drowsiness, dizziness, fatigue, and difficulty concentrating. In rare cases, severe adverse reactions such as respiratory depression or paradoxical reactions like agitation may occur.

Patients should strictly follow their doctor's recommendations and avoid alcohol or other substances that may enhance the sedative effects of alprazolam. Additionally, abrupt discontinuation of the medication should be avoided, as it may cause withdrawal symptoms. Alprazolam is an effective option for managing anxiety, but its use must be carefully monitored.

General data about ALPRAZOLAM GRINDEKS 0.5mg

Substance: alprazolam

Date of last drug list: 01-11-2024

Commercial code: W70585006

Concentration: 0.5mg

Pharmaceutical form: tablets

Quantity: 100

Product type: generic

Prescription restrictions: PS - Medicines with special prescription (narcotics and psychotropic drugs).

Marketing authorisation

Manufacturer: AS GRINDEKS - LETONIA

Holder: AS GRINDEKS - LETONIA

Number: 15609/2024/06

Shelf life: 2 years

Pharmaceutical forms available for alprazolam

Concentrations available for alprazolam

0.25mg, 0.5mg, 1mg, 2mg, 3mg